Symptomatic treatment of constipation

Usual dose: 1 infusion cup per cup, infusion, 1 to 4 cups per day.
The herbal tea should be prepared at the time of need and used immediately after
The treatment should be of short duration (maximum 8 to 10 days).

Senna and buccaneer, laxatives, anthracene-type stimulants stimulate colonic motility and change intestinal hydroelectric exchanges

Delay of action: 8 to 12 hours.

Boldo and Romarin are traditionally used for their properties, choleretic, cholagogues, promote digestion.

Not applicable.

Inflammatory organic colopathies (ulcerative colitis, Crohn's disease ...) Syndrome, occlusive or subocclusive, pain syndromes abdominal cause, indeterminate

Children under 12 years of age (except medical prescription).

Processing associated with

· Antiarrhythmics giving torsades de pointes: bepridil, la class anti-arrhythmic drugs (quinidine type), sotalol, amiodarone

· Lidoflazine, vincamine (non-arrhythmic drugs, leading to torsades).

Special warnings

Medicinal treatment of constipation is only an adjuvant to hygiene treatment

· Enrichment of vegetable fiber and drinks

· Physical activity counseling, rehabilitation of the exemption

Prolonged use of a laxative is not recommended.

In children, the prescription of laxatives, stimulant must be exceptional: it must take into account the risk of impeding the normal functioning of the exemption reflex. >
Prolonged intake of anthracene principles may lead to two series of disorders

· "Laxative disease" with functional colopathy, severe, rectocolic melanosis, abnormalities, hydroelectrolytes with hypokalaemia

A dependency situation with a regular need for laxatives, a need to increase the dosage and severe constipation in case of withdrawal, this dependence, which varies from one patient to another, can be created without the doctor's knowledge.

Associations, deprecated

Risk of hypokalaemia and thus of interactions, medicinal in case of association of a laxative stimulant, with

· Anti-arrhythmics giving torsades de pointes: bepridil, la class anti-arrhythmic drugs (quinidine type), sotalol, amiodarone

· Lidoflazine, vincamine (non-antiarrhythmic drugs, giving torsades de pointes).

Risk of torsades de pointes (hypokalaemia is a promoting factor as well as bradycardia and long pre-existing QT space), use a non-stimulating laxative

Associations, subject to precautions for use

· Digitalis: hypokalemia favoring toxic effects, digitalis.

· Other hypokalaemic agents: amphotericin B (lane IV), corticosteroids (gluco, mineral, general), tetracosactide, diuretics, hypokalaemicants (alone or in combination) Code>
Risk, increased by hypokalaemia (additive effect).
Monitoring of serum potassium and if need correction. Use a non-stimulating laxative.

Not applicable.

Symptoms: pain, abdominal, diarrhea.
Elimination of the ingested medication, correction of possible hydroelectrolytic disorders, in the event of a very significant fluid loss

Studies in animals have not demonstrated teratogenic effect. In the absence of teratogenic effect in animals, a malformative effect in the human species is not expected. Indeed, to date, the substances responsible for malformations in the human species have been shown to be teratogenic in animals during studies, well conducted on two species

Clinically, the use of senna in a limited number of pregnancies has apparently revealed no particular malformative or foetotoxic effects to date. However, further studies are needed to evaluate the consequences of exposure during pregnancy.

The use of this medication is discouraged during breastfeeding.

Possibility of diarrhea, abdominal pain especially in subjects suffering from irritable bowel, possibility of hypokalaemia

Symptomatic treatment of constipation